AFP and hepatocellular carcinoma: As such, HCC guidelines of European Association for the Study of the Liver [20] and the American Association for the Study of Liver Diseases [21] no longer recommend serum AFP measurement; however, a recent clinical study in China suggested that it is still a valuable biomarker for HBV-related HCC [22].